Advanced Dressings for CVC Infection Prevention in PICU

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-18
SponsorUniversity of Seville

About this trial

Randomised, single-blind clinical trial comparing chlorhexidine gluconate-impregnated transparent dressings versus conventional transparent dressings in the prevention of central venous catheter-related bloodstream infections (CVC-BSI) in paediatric patients admitted to a tertiary hospital PICU. Outcomes include incidence of BRCVC, catheter colonisation, dressing-related skin complications, and number of dressing changes.

Eligibility criteria

Qualifiers

Admission to paediatric intensive care unit (PICU)

Central venous catheter placement (central or peripherally inserted)

Informed consent obtained from parent/legal guardian

Disqualifiers

Known immunological disorders

Neutropenia (<500/mm³)

Pre-existing colonisation or infection with multidrug-resistant organisms

Trial design

Treatments tested in this trial

  • 3M™ Tegaderm™ Antimicrobial Transparent Dressing (chlorhexidine gluconate-impregnated)
  • Conventional transparent polyurethane dressing

Treatment groups

250 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Seville

Lead sponsor

Hospitales Universitarios Virgen del Rocío

Collaborator